Introduction {#Sec1}
============

Since coronavirus disease 2019 (COVID-19) emerged in December 2019, its rapid spread has overwhelmed healthcare systems, and it was ultimately declared a global pandemic in March 2020 by the World Health Organization \[[@CR1]\]. According to the Centers for Disease Control and Prevention (CDC), at the time of this writing, the USA has had 752,003 cases and 35,853 total deaths \[[@CR2]\]. New York City \[[@CR3]\], an epicenter of the disease, has been particularly hard hit, with data from the NYC Health Department showing 129,788 cases, 34,602 hospitalizations, and 8811 confirmed deaths \[[@CR3]\]. The scale of this public health crisis is unprecedented and presents unique challenges for radiology departments and hospitals alike.

The role of diagnostic imaging, namely computed tomography (CT), has been evolving in the evaluation of patients with suspected or confirmed COVID-19. Raptis et al. noted in a review of current literature that the current evidence as a whole should be considered "low quality," namely due to it consisting of retrospective studies and case series \[[@CR4]\]. Additionally, in a commentary to the Lancet by Hope et al., the authors note several challenges to using CT in COVID-19 cases and question its role. Recent guidelines from the Fleischner Society, however, acknowledge several potential scenarios and offer recommendations about when CT may be useful in the assessment of these patients. One of the main issues facing radiology departments is the risk of bringing an infected patient to the CT scanner and potentially exposing other uninfected patients and hospital staff to COVID-19 as it spreads through person to person contact or potentially from contaminated surfaces remains high \[[@CR5]\].

To manage infection control, some radiology departments have enacted emergency plans to re-route the workflow that could limit the potential transmission of COVID-19 \[[@CR6]--[@CR9]\]. For example, in our own department when transport of a patient is required from the UCC to the radiology department, the acuity of the patient's condition must be considered with regard to whether the scan can wait until the results of a COVID-19 swab are available. In addition, there are guidelines and recommendations for room disinfection after imaging patients which are evolving frequently, and these also factor into the process of imaging a patient with suspected or confirmed COVID-19 in the radiology department. Here, we summarize an initiative at our institution to re-purpose a portable CT scanner from the orthopedic operating room to the UCC for evaluation of COVID-19 patients.

Methods {#Sec2}
=======

The orthopedic and neurosurgery departments at our institution routinely use a portable CT scanner (Airo TruCT, Mobius Imaging LLC, Shirley, MA, USA) in the operating suite. As our department was eager to minimize the risk of disease transmission, elective orthopedic and neurosurgical surgeries were halted due to the COVID-19 pandemic, the scanner was re-purposed for use in the hospital's urgent care center (UCC), which is our institutional equivalent of an emergency department setting. Emergency services do not bring patients to our UCC.

Selection of space and room preparation {#Sec3}
---------------------------------------

An examination room with the appropriate dimensions within the UCC was selected for the portable CT unit. The room was shielded to reduce radiation exposure to staff and other patients in the UCC with lead-lined walls that complied with local regulations for shielding requirements of X-ray facilities. The portable CT unit has a self-drive system and requires a minimum width of hallways to be 4 ft for safe transport. The unit was brought from the orthopedic operating room to the UCC and positioned in the prepared room asymmetrically so that a stretcher could be wheeled in alongside it (Fig. [1](#Fig1){ref-type="fig"}). Portable suction, oxygen, emergency crash cart, and HEPA filtration device were the other furnishing items in the room as required by the Joint Commission and local regulatory standards.Fig. 1Image of the portable CT scanner set up in the emergency department at the Memorial Sloan Kettering Cancer Center

Technical parameters of portable CT scanner {#Sec4}
-------------------------------------------

The portable CT consists of 32 detectors, 1.06 mm in size in the longitudinal direction at isocenter (Airo Manual). It has one fixed beamwidth of 33.92 mm, and a fixed reconstruction slice thickness of 1.0 mm, in the same manner, a protocol for non-contrast CT chest in adult patients was programmed into the scanner with the following parameters: kV 120, mA 50, effective mAs 67.8, rotation time 1.92 seconds, slice collimation 1.06 mm, slice width 1.0 mm, feed/rotation 48 mm, pitch factor 1.415, and CTDI vol 10.1 mGy. No intravenous contrast was given, as the unit does not have a built in power injector.

Results {#Sec5}
=======

The first patient imaged with the portable CT scanner was a 48-year-old male with a history of lymphoma, presenting with fever and cough. A nasopharyngeal swab was positive for COVID-19. The patient was scanned inferior to superior with arms above the head. The total scan time was 20.2 seconds, and had a CTDIvol: 10.12 mGy, scan DLP of 483.46 mGy-cm^2^, and a scan length of 42.6 cm.

The non-contrast CT of the chest demonstrated new marked bilateral consolidations and associated ground-glass opacities, predominantly involving the lower lobes and posterior upper lobes (Fig. [2](#Fig2){ref-type="fig"}).Fig. 248-year-old male with non-Hodgkin lymphoma presented with fever and cough. Images acquired on the portable CT scanner (**a** and **b**) show bilateral consolidations and ground-glass opacities, consistent with COVID-19 infection. Images acquired on our departmental conventional CT scanner for the same patient 5 months prior to a routine staging scan are shown for comparison (**c** and **d**)

Discussion {#Sec6}
==========

Despite the technical limitations of re-purposing a portable CT scanner for use in the UCC, we were able to perform a non-contrast CT chest of diagnostic quality. There was initial concern that due to the fixed scanning parameters, the long exposure time would result in excessive respiratory motion, limiting the quality of the scan. However, the scanner performed adequately, with diagnostic quality images of a patient with confirmed COVID-19 infection.

Despite presenting with symptomatic pulmonary involvement of COVID-19, the patient was able to perform a 20.2 s breath-hold for the duration of the scan. The decision was made when the protocol was being designed to scan from inferior to superior, to minimize the effect of respiratory motion on the scan, which tends to occur most at the lung bases.

Although it is early in the world's experience with COVID-19, and the role of cross-sectional imaging remains indeterminate, it is important to consider options for obtaining CT of the chest when it is clinically indicated. Some have reported on the role of CT as a prognostic discriminator, with the ability to distinguish between critically ill or severely ill COVID-19 patients and so-called ordinary patients \[[@CR10]\]. In addition, the new Fleischner criteria outline certain circumstances in which diagnostic imaging may be warranted, including in patients who have moderate to severe clinical features regardless of COVID-19 status, or for those COVID-19 patients with worsening respiratory status \[[@CR11]\]. And although a portable radiograph may be preferable to non-contrast CT, given considerations of preventing transmission of infection, there are likely scenarios in which a non-contrast CT chest would provide diagnostically useful information. For those situations, a portable CT unit represents another tool in the radiologist's armamentarium that could be considered.

Use of a portable CT scanner has been reported in other situations when there is a clinical reason to do so, for example, to evaluate patients in pediatric \[[@CR12]\] or adult intensive care units \[[@CR13]\], or to expedite assessment of patients with acute stroke in the emergency department \[[@CR14]\]. Although we were able to obtain a diagnostic quality chest CT, it is important to remember our experience has been limited, and we do not know whether this will be the case as our patient cohort grows. One major limitation of this machine is the inability to use a power injector and administer intravenous contrast. The ability to evaluate for a pulmonary embolism, a scenario encountered in this population, is therefore unavailable and would require transport to the radiology department for a CT study. As these patients do present with embolic events and also shortness of breath, this is a clinically relevant limitation of its use.

In summary, we report here the successful implementation of a portable CT unit to perform non-contrast CT chest in an acutely ill COVID-19 patient in the hospital's UCC. Future reports on this technology in this setting will be needed to ensure it is robust and diagnostically acceptable. This may represent a safe method to allow hospitals to image COVID-19 patients for evaluation of lung parenchymal findings while minimizing transport throughout the hospital and therefore the potential spread of infection.
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